CA3176448A1 - Barcodable exchangeable peptide-mhc multimer libraries - Google Patents
Barcodable exchangeable peptide-mhc multimer librariesInfo
- Publication number
- CA3176448A1 CA3176448A1 CA3176448A CA3176448A CA3176448A1 CA 3176448 A1 CA3176448 A1 CA 3176448A1 CA 3176448 A CA3176448 A CA 3176448A CA 3176448 A CA3176448 A CA 3176448A CA 3176448 A1 CA3176448 A1 CA 3176448A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- mhci
- mhc
- multimerization domain
- conjugation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003177P | 2020-03-31 | 2020-03-31 | |
| US63/003,177 | 2020-03-31 | ||
| PCT/US2021/025167 WO2021202727A2 (en) | 2020-03-31 | 2021-03-31 | Barcodable exchangeable peptide-mhc multimer libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3176448A1 true CA3176448A1 (en) | 2021-10-07 |
Family
ID=75660333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3176448A Pending CA3176448A1 (en) | 2020-03-31 | 2021-03-31 | Barcodable exchangeable peptide-mhc multimer libraries |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230287394A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4126923A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7846628B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115776987A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021248941A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3176448A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296789A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021202727A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114644706B (zh) * | 2022-02-16 | 2024-04-09 | 国家纳米科学中心 | 基于DNA纳米技术的pMHC多聚体制备方法及其应用 |
| WO2024026452A1 (en) | 2022-07-29 | 2024-02-01 | Repertoire Immune Medicines, Inc. | T cell epitopes associated with type 1 diabetes |
| WO2025072849A1 (en) | 2023-09-29 | 2025-04-03 | Repertoire Immune Medicines, Inc. | Mhc-presentable peptides associated with type 1 diabetes |
| WO2025137580A1 (en) * | 2023-12-22 | 2025-06-26 | Antiger Therapeutics, Inc. | Class ii hla with inter-chain disulfide bond |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| NO155316C (no) | 1982-04-23 | 1987-03-11 | Sintef | Fremgangsmaate for fremstilling av magnetiske polymerpartikler. |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US5672502A (en) | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| AU3220593A (en) | 1991-11-19 | 1993-06-15 | Anergen, Inc. | Soluble mhc molecules and their uses |
| DE4237113B4 (de) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| ATE139900T1 (de) | 1992-11-13 | 1996-07-15 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| DE19641876B4 (de) | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
| DE10247014A1 (de) * | 2002-10-09 | 2004-04-22 | Erfle, Volker, Prof. Priv.-Doz. Dr. | MHC-Multimere |
| GB0226227D0 (en) * | 2002-11-09 | 2002-12-18 | Avidex Ltd | Receptors |
| WO2005047902A1 (en) | 2003-11-03 | 2005-05-26 | Beckman Coulter, Inc. | Solution-based methods for detecting mhc-binding peptides |
| GB2422834B8 (en) * | 2005-02-04 | 2007-01-04 | Proimmune Ltd | MHC oligomer and method of making the same |
| WO2006136763A1 (en) * | 2005-06-20 | 2006-12-28 | Medigene Limited | Synthetic ligands of peptide-mhc complexes, or cd1-antigen complexes |
| GB2430256B (en) | 2005-09-19 | 2008-06-25 | Proimmune Ltd | A method of screening MHC molecules |
| WO2009003493A2 (en) * | 2007-07-03 | 2009-01-08 | Dako Denmark A/S | Mhc multimers, methods for their generation, labeling and use |
| TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之egfr/igfir結合分子 |
| EP2396000A1 (en) | 2009-02-11 | 2011-12-21 | Bristol-Myers Squibb Company | Combination vegfr2 therapy with temozolomide |
| DK2558491T3 (en) | 2010-04-13 | 2018-10-15 | Bristol Myers Squibb Co | Fibronectin-based Scaffold domain proteins that bind PCSK9 |
| CN102296807B (zh) | 2011-06-27 | 2013-06-05 | 中国葛洲坝集团股份有限公司 | 管、槽圆弧形混凝土底板轻便滑模 |
| RU2014132426A (ru) * | 2012-01-06 | 2016-02-27 | Орегон Хэлт Энд Сайенс Юниверсити | Частичные конструкты мнс и способы их применения |
| US10816554B2 (en) * | 2014-04-04 | 2020-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Ligand discovery for T cell receptors |
| EP2952520A1 (en) * | 2014-06-06 | 2015-12-09 | Stichting Sanquin Bloedvoorziening | Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides. |
| AU2015271324B2 (en) * | 2014-06-06 | 2019-09-12 | Herlev Hospital | Determining antigen recognition through barcoding of MHC multimers |
| CN114214314A (zh) | 2014-06-24 | 2022-03-22 | 生物辐射实验室股份有限公司 | 数字式pcr条码化 |
| EP3752832A1 (en) * | 2018-02-12 | 2020-12-23 | 10X Genomics, Inc. | Methods characterizing multiple analytes from individual cells or cell populations |
| WO2019238939A1 (en) * | 2018-06-15 | 2019-12-19 | F. Hoffmann-La Roche Ag | A system for identification of antigens recognized by t cell receptors expressed on tumor infiltrating lymphocytes |
| CA3125556A1 (en) * | 2019-01-04 | 2020-07-09 | Repertoire Immune Medicines, Inc. | Methods of producing high diversity peptide libraries and promoting protein folding |
-
2021
- 2021-03-31 WO PCT/US2021/025167 patent/WO2021202727A2/en not_active Ceased
- 2021-03-31 IL IL296789A patent/IL296789A/en unknown
- 2021-03-31 AU AU2021248941A patent/AU2021248941A1/en active Pending
- 2021-03-31 US US17/995,074 patent/US20230287394A1/en active Pending
- 2021-03-31 CA CA3176448A patent/CA3176448A1/en active Pending
- 2021-03-31 EP EP21721278.6A patent/EP4126923A2/en active Pending
- 2021-03-31 JP JP2022559619A patent/JP7846628B2/ja active Active
- 2021-03-31 CN CN202180039282.4A patent/CN115776987A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230287394A1 (en) | 2023-09-14 |
| WO2021202727A3 (en) | 2021-12-09 |
| WO2021202727A2 (en) | 2021-10-07 |
| EP4126923A2 (en) | 2023-02-08 |
| CN115776987A (zh) | 2023-03-10 |
| JP7846628B2 (ja) | 2026-04-15 |
| IL296789A (en) | 2022-11-01 |
| AU2021248941A1 (en) | 2022-11-17 |
| JP2023520412A (ja) | 2023-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230265157A1 (en) | Mhc multimer expression constructs and uses thereof | |
| US11668705B2 (en) | General detection and isolation of specific cells by binding of labeled molecules | |
| US20230287394A1 (en) | Barcodable exchangeable peptide-mhc multimer libraries | |
| US20220033460A1 (en) | Identification and use of t cell epitopes in designing diagnostic and therapeutic approaches for covid-19 | |
| US20220162695A1 (en) | Use of dextramer in single cell analysis | |
| US20110236411A1 (en) | MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics | |
| US20100226854A1 (en) | MHC Peptide Complexes and Uses Thereof in Infectious Diseases | |
| US20220090297A1 (en) | Peptide libraries and methods of use thereof | |
| NZ724320A (en) | Tcr libraries | |
| US20220088135A1 (en) | Methods of making and using soluble mhc molecules | |
| WO2022087154A1 (en) | Mhc class ii peptide multimers and uses thereof | |
| US20240076356A1 (en) | Display of peptide-mhc (pmhc) on multimeric protein scaffolds and uses thereof | |
| US20200347103A1 (en) | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics | |
| HK40095794A (en) | General detection and isolation of specific cells by binding of labeled molecules | |
| CN118355277A (zh) | 评定mhc-肽-tcr相互作用和动力学的细胞测定和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220921 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250415 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250516 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250516 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250815 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250819 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251022 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251022 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251127 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260327 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260327 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20260420 |